Short interest in XTL Biopharmaceuticals Ltd (NASDAQ:XTLB) increased during the last reporting period, rising from 70.82K to 92.14K. This put 2.23% of the company's publicly available shares short.

Short interest for XTL Biopharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of XTL Biopharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 16.64K shares traded per day, it would take 5.54 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.